COSCIENS Biopharma, Inc. (CSCI.TO)
1.96
+0.06
(+3.16%)
CAD |
TSX |
Mar 13, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 6.239M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -59.17% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 0.4894 |
| Price to Book Value | 0.8826 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.4274 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.36% |
Profile
| COSCIENS Biopharma Inc. engages in the development and commercialization of diverse pharmaceutical and diagnostic products. It operates through the Active Ingredient and Biopharmaceutical segments. The Active Ingredient segment is involved in the development of proprietary extraction technologies. The Biopharmaceutical segment includes commercializing and developing pharmaceutical therapeutics and diagnostic tests. The company was founded on September 12, 1990 and is headquartered in Toronto, Canada. |
| URL | http://www.cosciensbio.com |
| Investor Relations URL | https://www.cosciensbio.com/overview-1 |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| COSCIENS Biopharma Inc. engages in the development and commercialization of diverse pharmaceutical and diagnostic products. It operates through the Active Ingredient and Biopharmaceutical segments. The Active Ingredient segment is involved in the development of proprietary extraction technologies. The Biopharmaceutical segment includes commercializing and developing pharmaceutical therapeutics and diagnostic tests. The company was founded on September 12, 1990 and is headquartered in Toronto, Canada. |
| URL | http://www.cosciensbio.com |
| Investor Relations URL | https://www.cosciensbio.com/overview-1 |
| HQ State/Province | Ontario |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |